Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Denosumab on Disseminated Tumor Cells in Early Stage Breast Cancer
NCT01545648Phase 2Terminated
- Sponsor
- Hope Rugo
- Start
- Nov 2012
- Primary completion
- Jun 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in breast cancer, sponsored by Hope Rugo. Started Nov 2012; status: terminated.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01545648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01545648.